Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Edoxaban vs Warfarin in CTEPH (KABUKI)
NCT04730037Phase 3Completed
- Sponsor
- Kyushu University
- Start
- Mar 2021
- Primary completion
- Mar 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of edoxaban in chronic thromboembolic pulmonary hypertension (CTEPH), sponsored by Kyushu University. Started Mar 2021; status: completed.
02
Drugs
edoxaban
03
Conditions
chronic thromboembolic pulmonary hypertension (CTEPH)
Beyond the preview
Go deeper on NCT04730037.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04730037.